| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 92 |
| 1 | ACETAMINOPHEN | 66 |
| 2 | ASPIRIN | 65 |
| 3 | ASPIRIN 325 MG | 62 |
| 4 | ASPIRIN 81 MG | 62 |
| 5 | METHOTREXATE SODIUM | 58 |
| 6 | METHOTREXATE | 56 |
| 7 | OMEPRAZOLE MAGNESIUM | 48 |
| 8 | ACETAMINOPHEN 500MG | 44 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 8 | 0.0035 |
| 1 | ERGOCALCIFEROL | 39 | 0.0013 |
| 2 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 16 | 0.0013 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 10 | 0.0012 |
| 4 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 7 | 0.0010 |
| 5 | PEGASPARGASE | 12 | 0.0010 |
| 6 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 7 | TEDUGLUTIDE | 12 | 0.0009 |
| 8 | AVACOPAN | 6 | 0.0009 |
| 9 | MERCAPTOPURINE | 15 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 153 |
| 1 | Corticosteroid [EPC] | 107 |
| 2 | Benzodiazepine [EPC] | 73 |
| 3 | Kinase Inhibitor [EPC] | 70 |
| 4 | GLP-1 Receptor Agonist [EPC] | 68 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 66 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 65 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 56 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 55 |
| 9 | Vitamin C [EPC] | 55 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 2 | 0.0019 |
| 1 | alpha-Hydroxy Acid [EPC] | 4 | 0.0018 |
| 2 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | CD22-directed Immunoconjugate [EPC] | 4 | 0.0013 |
| 5 | Provitamin D2 Compound [EPC] | 39 | 0.0013 |
| 6 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 7 | Asparagine-specific Enzyme [EPC] | 13 | 0.0010 |
| 8 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 9 | GLP-2 Analog [EPC] | 12 | 0.0009 |